Echo Therapeutics (ECTE) Reports Q3 Loss of $0.16/Share
Tweet
Share
E-mailGet Alerts ECTE Hot Sheet
Join SI Premium – FREE
Echo Therapeutics (NASDAQ: ECTE) reported Q3 EPS of ($0.16), versus ($0.21) reported last year.
For earnings history and earnings-related data on Echo Therapeutics (ECTE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c
- Mannatech (MTEX) Tops Q2 EPS by 53c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
